TY - JOUR T1 - Statins do not improve cardiovascular outcomes for dialysis patients JF - Evidence Based Medicine JO - Evid Based Med SP - 89 LP - 89 DO - 10.1136/eb-2013-101606 VL - 19 IS - 3 AU - Ali Olyaei Y1 - 2014/06/01 UR - http://ebm.bmj.com/content/19/3/89.abstract N2 - Commentary on: Palmer SC, Navaneethan SD, Craig JC, et al. HMG CoA reductase inhibitors (statins) for dialysis patients: a systematic review and meta-analysis. Cochrane Database Syst Rev 2013;(9):CD004289. Chronic kidney disease affected nearly 19 million people in the USA, with incidence increasing globally at an annual rate of 8%, most of which were unrecognised or undiagnosed. Cardiovascular events are common among patients with chronic kidney disease and highest in dialysis patients. While dialysis patients experience a high prevalence of traditional risk factors for cardiovascular disease (CVD), such as hypertension, diabetes, hyperlipidaemia and obesity, CVD in such patients is driven predominately by non-traditional risk factors such as anaemia, calcium/phosphate calcification, proteinuria, oxidative stress and uraemic hyper coagulopathy. Approximately 25% of deaths are related to traditional … ER -